Reperfusion injury or reperfusion insult, sometimes called ischemia-reperfusion injury (IRI) or reoxygenation injury, is the tissue damage caused when blood supply returns to tissue (re- + perfusion) after a period of ischemia or lack of oxygen (anoxia or hypoxia). The absence of oxygen and nutrients from blood during the ischemic period creates a condition in which the restoration of circulation results in inflammation and oxidative damage through the induction of oxidative stress rather than (or along with) restoration of normal function.
Market Analysis and Insights: Global Ischemia Reperfusion Injury Market
The global Ischemia Reperfusion Injury market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
Global Ischemia Reperfusion Injury key players include Angion Biomedica, Catalyst Biosciences, Ischemix Inc, etc.
North America is the largest market, with a share about 50%, followed by Europe, and Japan, both have a share over 20 percent.
In terms of product, Phase 2 is the largest segment, with a share about 40%. And in terms of application, the largest application is Kidney Injury, followed by Heart Injury, Intestine Injury, etc.
Report Covers:
This report presents an overview of global market for Ischemia Reperfusion Injury market size. Analyses of the global market trends, with historic market revenue data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Ischemia Reperfusion Injury, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Ischemia Reperfusion Injury, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Ischemia Reperfusion Injury revenue, market share and industry ranking of main companies, data from 2019 to 2024. Identification of the major stakeholders in the global Ischemia Reperfusion Injury market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2019 to 2030. Evaluation and forecast the market size for Ischemia Reperfusion Injury revenue, projected growth trends, production technology, application and end-user industry.
Market Segmentation
By Company
Angion Biomedica
Catalyst Biosciences
Ischemix Inc
Opsona Therapeutics
Pharming
TheraSource
Bolder Biotechnology
Corline Biomedical
Mifcortx
Balmes Transplantation
NovelMed Therapeutics
Hope Pharmaceuticals
Omeros Corp
Prothix
SBI Pharmaceuticals
Segment by Type
Phase 1
Phase 2
Preclinical
Segment by Application
Heart Injury
Kidney Injury
Intestine Injury
Other Injury
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Revenue of Ischemia Reperfusion Injury in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Ischemia Reperfusion Injury companies鈥� competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Application and by country, revenue for each segment.
Chapter 7: Europe by Type, by Application and by country, revenue for each segment.
Chapter 8: China by Type, and by Application, revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by Application and by region, revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, revenue for each segment.
Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Ischemia Reperfusion Injury revenue, gross margin, and recent development, etc.
Chapter 12: Analyst's Viewpoints/Conclusions
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Ischemia Reperfusion Injury Market Size Growth Rate by Type, 2019 VS 2023 VS 2030
1.2.2 Phase 1
1.2.3 Phase 2
1.2.4 Preclinical
1.3 Market by Application
1.3.1 Global Ischemia Reperfusion Injury Market Size Growth Rate by Application, 2019 VS 2023 VS 2030
1.3.2 Heart Injury
1.3.3 Kidney Injury
1.3.4 Intestine Injury
1.3.5 Other Injury
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Ischemia Reperfusion Injury Market Perspective (2019-2030)
2.2 Global Ischemia Reperfusion Injury Growth Trends by Region
2.2.1 Ischemia Reperfusion Injury Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Ischemia Reperfusion Injury Historic Market Size by Region (2019-2024)
2.2.3 Ischemia Reperfusion Injury Forecasted Market Size by Region (2025-2030)
2.3 Ischemia Reperfusion Injury Market Dynamics
2.3.1 Ischemia Reperfusion Injury Industry Trends
2.3.2 Ischemia Reperfusion Injury Market Drivers
2.3.3 Ischemia Reperfusion Injury Market Challenges
2.3.4 Ischemia Reperfusion Injury Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue Ischemia Reperfusion Injury by Players
3.1.1 Global Ischemia Reperfusion Injury Revenue by Players (2019-2024)
3.1.2 Global Ischemia Reperfusion Injury Revenue Market Share by Players (2019-2024)
3.2 Global Ischemia Reperfusion Injury Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Ischemia Reperfusion Injury, Ranking by Revenue, 2022 VS 2023 VS 2024
3.4 Global Ischemia Reperfusion Injury Market Concentration Ratio
3.4.1 Global Ischemia Reperfusion Injury Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Ischemia Reperfusion Injury Revenue in 2023
3.5 Global Key Players of Ischemia Reperfusion Injury Head office and Area Served
3.6 Global Key Players of Ischemia Reperfusion Injury, Product and Application
3.7 Global Key Players of Ischemia Reperfusion Injury, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Ischemia Reperfusion Injury Breakdown Data by Type
4.1 Global Ischemia Reperfusion Injury Historic Market Size by Type (2019-2024)
4.2 Global Ischemia Reperfusion Injury Forecasted Market Size by Type (2025-2030)
5 Ischemia Reperfusion Injury Breakdown Data by Application
5.1 Global Ischemia Reperfusion Injury Historic Market Size by Application (2019-2024)
5.2 Global Ischemia Reperfusion Injury Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Ischemia Reperfusion Injury Market Size (2019-2030)
6.2 North America Ischemia Reperfusion Injury Market Size by Type
6.2.1 North America Ischemia Reperfusion Injury Market Size by Type (2019-2024)
6.2.2 North America Ischemia Reperfusion Injury Market Size by Type (2025-2030)
6.2.3 North America Ischemia Reperfusion Injury Market Share by Type (2019-2030)
6.3 North America Ischemia Reperfusion Injury Market Size by Application
6.3.1 North America Ischemia Reperfusion Injury Market Size by Application (2019-2024)
6.3.2 North America Ischemia Reperfusion Injury Market Size by Application (2025-2030)
6.3.3 North America Ischemia Reperfusion Injury Market Share by Application (2019-2030)
6.4 North America Ischemia Reperfusion Injury Market Size by Country
6.4.1 North America Ischemia Reperfusion Injury Market Size by Country: 2019 VS 2023 VS 2030
6.4.2 North America Ischemia Reperfusion Injury Market Size by Country (2019-2024)
6.4.3 North America Ischemia Reperfusion Injury Market Size by Country (2025-2030)
6.4.4 U.S.
6.4.5 Canada
7 Europe
7.1 Europe Ischemia Reperfusion Injury Market Size (2019-2030)
7.2 Europe Ischemia Reperfusion Injury Market Size by Type
7.2.1 Europe Ischemia Reperfusion Injury Market Size by Type (2019-2024)
7.2.2 Europe Ischemia Reperfusion Injury Market Size by Type (2025-2030)
7.2.3 Europe Ischemia Reperfusion Injury Market Share by Type (2019-2030)
7.3 Europe Ischemia Reperfusion Injury Market Size by Application
7.3.1 Europe Ischemia Reperfusion Injury Market Size by Application (2019-2024)
7.3.2 Europe Ischemia Reperfusion Injury Market Size by Application (2025-2030)
7.3.3 Europe Ischemia Reperfusion Injury Market Share by Application (2019-2030)
7.4 Europe Ischemia Reperfusion Injury Market Size by Country
7.4.1 Europe Ischemia Reperfusion Injury Market Size by Country: 2019 VS 2023 VS 2030
7.4.2 Europe Ischemia Reperfusion Injury Market Size by Country (2019-2024)
7.4.3 Europe Ischemia Reperfusion Injury Market Size by Country (2025-2030)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China Ischemia Reperfusion Injury Market Size (2019-2030)
8.2 China Ischemia Reperfusion Injury Market Size by Type
8.2.1 China Ischemia Reperfusion Injury Market Size by Type (2019-2024)
8.2.2 China Ischemia Reperfusion Injury Market Size by Type (2025-2030)
8.2.3 China Ischemia Reperfusion Injury Market Share by Type (2019-2030)
8.3 China Ischemia Reperfusion Injury Market Size by Application
8.3.1 China Ischemia Reperfusion Injury Market Size by Application (2019-2024)
8.3.2 China Ischemia Reperfusion Injury Market Size by Application (2025-2030)
8.3.3 China Ischemia Reperfusion Injury Market Share by Application (2019-2030)
9 Asia (excluding China)
9.1 Asia Ischemia Reperfusion Injury Market Size (2019-2030)
9.2 Asia Ischemia Reperfusion Injury Market Size by Type
9.2.1 Asia Ischemia Reperfusion Injury Market Size by Type (2019-2024)
9.2.2 Asia Ischemia Reperfusion Injury Market Size by Type (2025-2030)
9.2.3 Asia Ischemia Reperfusion Injury Market Share by Type (2019-2030)
9.3 Asia Ischemia Reperfusion Injury Market Size by Application
9.3.1 Asia Ischemia Reperfusion Injury Market Size by Application (2019-2024)
9.3.2 Asia Ischemia Reperfusion Injury Market Size by Application (2025-2030)
9.3.3 Asia Ischemia Reperfusion Injury Market Share by Application (2019-2030)
9.4 Asia Ischemia Reperfusion Injury Market Size by Region
9.4.1 Asia Ischemia Reperfusion Injury Market Size by Region: 2019 VS 2023 VS 2030
9.4.2 Asia Ischemia Reperfusion Injury Market Size by Region (2019-2024)
9.4.3 Asia Ischemia Reperfusion Injury Market Size by Region (2025-2030)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America Ischemia Reperfusion Injury Market Size (2019-2030)
10.2 Middle East, Africa, and Latin America Ischemia Reperfusion Injury Market Size by Type
10.2.1 Middle East, Africa, and Latin America Ischemia Reperfusion Injury Market Size by Type (2019-2024)
10.2.2 Middle East, Africa, and Latin America Ischemia Reperfusion Injury Market Size by Type (2025-2030)
10.2.3 Middle East, Africa, and Latin America Ischemia Reperfusion Injury Market Share by Type (2019-2030)
10.3 Middle East, Africa, and Latin America Ischemia Reperfusion Injury Market Size by Application
10.3.1 Middle East, Africa, and Latin America Ischemia Reperfusion Injury Market Size by Application (2019-2024)
10.3.2 Middle East, Africa, and Latin America Ischemia Reperfusion Injury Market Size by Application (2025-2030)
10.3.3 Middle East, Africa, and Latin America Ischemia Reperfusion Injury Market Share by Application (2019-2030)
10.4 Middle East, Africa, and Latin America Ischemia Reperfusion Injury Market Size by Country
10.4.1 Middle East, Africa, and Latin America Ischemia Reperfusion Injury Market Size by Country: 2019 VS 2023 VS 2030
10.4.2 Middle East, Africa, and Latin America Ischemia Reperfusion Injury Market Size by Country (2019-2024)
10.4.3 Middle East, Africa, and Latin America Ischemia Reperfusion Injury Market Size by Country (2025-2030)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 Angion Biomedica
11.1.1 Angion Biomedica Company Details
11.1.2 Angion Biomedica Business Overview
11.1.3 Angion Biomedica Ischemia Reperfusion Injury Introduction
11.1.4 Angion Biomedica Revenue in Ischemia Reperfusion Injury Business (2019-2024)
11.1.5 Angion Biomedica Recent Developments
11.2 Catalyst Biosciences
11.2.1 Catalyst Biosciences Company Details
11.2.2 Catalyst Biosciences Business Overview
11.2.3 Catalyst Biosciences Ischemia Reperfusion Injury Introduction
11.2.4 Catalyst Biosciences Revenue in Ischemia Reperfusion Injury Business (2019-2024)
11.2.5 Catalyst Biosciences Recent Developments
11.3 Ischemix Inc
11.3.1 Ischemix Inc Company Details
11.3.2 Ischemix Inc Business Overview
11.3.3 Ischemix Inc Ischemia Reperfusion Injury Introduction
11.3.4 Ischemix Inc Revenue in Ischemia Reperfusion Injury Business (2019-2024)
11.3.5 Ischemix Inc Recent Developments
11.4 Opsona Therapeutics
11.4.1 Opsona Therapeutics Company Details
11.4.2 Opsona Therapeutics Business Overview
11.4.3 Opsona Therapeutics Ischemia Reperfusion Injury Introduction
11.4.4 Opsona Therapeutics Revenue in Ischemia Reperfusion Injury Business (2019-2024)
11.4.5 Opsona Therapeutics Recent Developments
11.5 Pharming
11.5.1 Pharming Company Details
11.5.2 Pharming Business Overview
11.5.3 Pharming Ischemia Reperfusion Injury Introduction
11.5.4 Pharming Revenue in Ischemia Reperfusion Injury Business (2019-2024)
11.5.5 Pharming Recent Developments
11.6 TheraSource
11.6.1 TheraSource Company Details
11.6.2 TheraSource Business Overview
11.6.3 TheraSource Ischemia Reperfusion Injury Introduction
11.6.4 TheraSource Revenue in Ischemia Reperfusion Injury Business (2019-2024)
11.6.5 TheraSource Recent Developments
11.7 Bolder Biotechnology
11.7.1 Bolder Biotechnology Company Details
11.7.2 Bolder Biotechnology Business Overview
11.7.3 Bolder Biotechnology Ischemia Reperfusion Injury Introduction
11.7.4 Bolder Biotechnology Revenue in Ischemia Reperfusion Injury Business (2019-2024)
11.7.5 Bolder Biotechnology Recent Developments
11.8 Corline Biomedical
11.8.1 Corline Biomedical Company Details
11.8.2 Corline Biomedical Business Overview
11.8.3 Corline Biomedical Ischemia Reperfusion Injury Introduction
11.8.4 Corline Biomedical Revenue in Ischemia Reperfusion Injury Business (2019-2024)
11.8.5 Corline Biomedical Recent Developments
11.9 Mifcortx
11.9.1 Mifcortx Company Details
11.9.2 Mifcortx Business Overview
11.9.3 Mifcortx Ischemia Reperfusion Injury Introduction
11.9.4 Mifcortx Revenue in Ischemia Reperfusion Injury Business (2019-2024)
11.9.5 Mifcortx Recent Developments
11.10 Balmes Transplantation
11.10.1 Balmes Transplantation Company Details
11.10.2 Balmes Transplantation Business Overview
11.10.3 Balmes Transplantation Ischemia Reperfusion Injury Introduction
11.10.4 Balmes Transplantation Revenue in Ischemia Reperfusion Injury Business (2019-2024)
11.10.5 Balmes Transplantation Recent Developments
11.11 NovelMed Therapeutics
11.11.1 NovelMed Therapeutics Company Details
11.11.2 NovelMed Therapeutics Business Overview
11.11.3 NovelMed Therapeutics Ischemia Reperfusion Injury Introduction
11.11.4 NovelMed Therapeutics Revenue in Ischemia Reperfusion Injury Business (2019-2024)
11.11.5 NovelMed Therapeutics Recent Developments
11.12 Hope Pharmaceuticals
11.12.1 Hope Pharmaceuticals Company Details
11.12.2 Hope Pharmaceuticals Business Overview
11.12.3 Hope Pharmaceuticals Ischemia Reperfusion Injury Introduction
11.12.4 Hope Pharmaceuticals Revenue in Ischemia Reperfusion Injury Business (2019-2024)
11.12.5 Hope Pharmaceuticals Recent Developments
11.13 Omeros Corp
11.13.1 Omeros Corp Company Details
11.13.2 Omeros Corp Business Overview
11.13.3 Omeros Corp Ischemia Reperfusion Injury Introduction
11.13.4 Omeros Corp Revenue in Ischemia Reperfusion Injury Business (2019-2024)
11.13.5 Omeros Corp Recent Developments
11.14 Prothix
11.14.1 Prothix Company Details
11.14.2 Prothix Business Overview
11.14.3 Prothix Ischemia Reperfusion Injury Introduction
11.14.4 Prothix Revenue in Ischemia Reperfusion Injury Business (2019-2024)
11.14.5 Prothix Recent Developments
11.15 SBI Pharmaceuticals
11.15.1 SBI Pharmaceuticals Company Details
11.15.2 SBI Pharmaceuticals Business Overview
11.15.3 SBI Pharmaceuticals Ischemia Reperfusion Injury Introduction
11.15.4 SBI Pharmaceuticals Revenue in Ischemia Reperfusion Injury Business (2019-2024)
11.15.5 SBI Pharmaceuticals Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Angion Biomedica
Catalyst Biosciences
Ischemix Inc
Opsona Therapeutics
Pharming
TheraSource
Bolder Biotechnology
Corline Biomedical
Mifcortx
Balmes Transplantation
NovelMed Therapeutics
Hope Pharmaceuticals
Omeros Corp
Prothix
SBI Pharmaceuticals
听
听
*If Applicable.
